Clinical trial
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent…
NCT00003449 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00003449 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer |
| Official title | Phase II Study of Weekly Paclitaxel and Gemcitabine in Platinum-Resistant Ovarian Cancer |
| Lead sponsor | University of Southern California, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | dexamethasone, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 35 |
| Start date | May 1, 1998 |
| Primary completion | Jun 1, 2002 |
| Completion | Feb 1, 2004 |
| First posted | Sep 24, 2003 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: